Cargando…
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey
INTRODUCTION: Pulmonary fibrosis (PF) and its most common form, idiopathic pulmonary fibrosis (IPF), are chronic, progressive diseases resulting in increasing loss of lung function and impaired quality of life and survival. The aim of this joint expert and patient statement was to highlight the most...
Autores principales: | Moor, Catharina C., Wijsenbeek, Marlies S., Balestro, Elisabetta, Biondini, Davide, Bondue, Benjamin, Cottin, Vincent, Flewett, Ron, Galvin, Liam, Jones, Steve, Molina-Molina, Maria, Planas-Cerezales, Lurdes, Prasse, Antje, Prosch, Helmut, Russell, Anne-Marie, Viegas, Michel, Wanke, Guenther, Wuyts, Wim, Kreuter, Michael, Bonella, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801215/ https://www.ncbi.nlm.nih.gov/pubmed/31649949 http://dx.doi.org/10.1183/23120541.00124-2019 |
Ejemplares similares
-
Research highlights from the 2018 ERS International Congress: interstitial lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2019) -
Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
por: Nakshbandi, Gizal, et al.
Publicado: (2023) -
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly
por: Guler, Sabina A., et al.
Publicado: (2022) -
Harnessing PM2.5 Exposure Data to Predict Progression of Fibrotic Interstitial Lung Diseases Based on Telomere Length
por: Shull, Jessica Germaine, et al.
Publicado: (2022) -
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015)